Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.
about
Clinical applications of mesenchymal stem cellsEpithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cellsStrategies to improve the immunosuppressive properties of human mesenchymal stem cellsPatient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentMesenchymal stem cell secretome and regenerative therapy after cancerIntravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils.Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapyMicroenvironmental regulation of metastasisClinical applications of mesenchymal stem cells in chronic diseases.The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progressionIn vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages.Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Stem cell paracrine actions and tissue regeneration.Anti-inflammatory Effects of Oct4/Sox2-overexpressing Human Adipose Tissue-derived Mesenchymal Stem Cells.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitisMesenchymal stem cell therapy: Two steps forward, one step backHelicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-κB-dependent pathwayRegenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cellsDirect evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging.Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells.Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model.Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cellsMesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells.Directing systemic oncolytic viral delivery to tumors via carrier cellsAltered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.
P2860
Q21198864-D386949C-8865-444D-B783-B6705389BD57Q24599620-F9E328FA-0C15-40F1-90CD-CA814F1A9F9DQ26786626-DD395221-1639-4F6F-BEF2-1E9EE2CEB529Q26821929-BCA8ADB9-76A0-427F-8AED-FAB5BA39D134Q26853374-46375604-6B74-45C1-A3F6-CCE5877AB898Q27007499-49D34A01-285E-4A70-8B33-D1C22E894281Q27329981-B51003FC-0D51-467C-A8F0-BAA70E0219B6Q28082334-E784465A-18BC-4863-874B-4DCDDAB8E20EQ29547660-8DC6F7EE-98AA-4D5C-9940-67835A493E4BQ30437823-6AEF86E6-7169-4E29-BEAE-6BEAF5250745Q30486489-D449011F-1C45-4D84-8A00-EC4E0C11C4E8Q30621190-CE6C65C9-214C-4904-AA51-FB35DFE87F66Q30690412-C0DEEB6D-5F12-42FF-B8EA-832EC1B54F47Q30882988-FA060C0C-8F2C-49BE-8BDA-1A6C5F28F43FQ33427809-50A17427-373C-47B7-9246-79B556324003Q33495594-17DF49F6-677F-4A17-B6F2-E929B068693AQ33560685-97E651FB-15C0-4212-89D8-C3F5E28C9719Q33708216-A37312A0-FAD3-4775-9DB7-470D7E06EBAFQ33770758-1FC90A85-D425-43EE-87F3-E4245A19BCC6Q33786788-6CA740E0-381F-48A7-882B-DE7C7036CA31Q33789162-DC8640F0-6434-4D17-A225-8DAAE33333BBQ33898618-1C6D21F9-8013-46B8-B4A0-CF7AB4CA3EB0Q33898653-25164300-D17D-4091-ABD2-E27560436D3DQ34117121-D1E56D9E-F990-4115-8368-8DBFA9A08167Q34138063-54F14E8E-1435-49A3-8E45-8BC9A0F6B333Q34154904-F3EE5C69-5932-4468-928F-CD8E3C7B0E6CQ34162598-871C479C-6C09-4CF3-89D8-820555659BB0Q34164696-D919BEA2-EA29-4498-B493-56C04203BAA7Q34230447-36B8E938-2A0F-44DA-9B10-CEF0A47C678BQ34294935-9746EA86-D151-4AAC-A7F5-C558DBD524A6Q34321571-3C0B55B8-4BF8-4C51-A97C-26A86821A989Q34401933-00481AD9-CDCF-4970-A6A0-4074989F4FABQ34411454-7AE82D65-3B2A-40CE-B93A-BF38415C54C1Q34422955-16A2ABA5-A0E4-4FB1-9939-ACD22DFA75ECQ34424820-8CBDF75A-B5D6-4AF6-B1BE-7C028DB3B28FQ34465378-1450213C-79A4-4BD3-BB44-29904F5FA547Q34710895-9E3256CF-754A-418A-8C80-044698C52DAEQ34920741-711C6585-3633-4F68-9D2E-AE35156CB1B6Q35029126-07C6D340-5C3C-4909-91F6-00D713F8726FQ35037638-73A98EAD-ADAA-4556-AA11-CE295493348A
P2860
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@en
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@nl
type
label
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@en
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@nl
prefLabel
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@en
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Inflammation and tumor microen ...... ary of mesenchymal stem cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.39
P577
2008-04-10T00:00:00Z